The role of HOXA1 in cancer and targeted therapy.
Saved in:
| Title: | The role of HOXA1 in cancer and targeted therapy. |
|---|---|
| Authors: | Dong J; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China. jdong@zzu.edu.cn., Gong H; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China., Li J; China-US(Henan) Hormel Cancer Institute, No.127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China., Ma X; China-US(Henan) Hormel Cancer Institute, No.127, Dongming Road, Jinshui District, Zhengzhou, 450008, Henan, China., Tayyab B; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China., Xu X; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn.; Key Laboratory of Henan Province for Drug Quality and Evaluation, Zhengzhou University, Zhengzhou, 450001, China. xuxia@zzu.edu.cn. |
| Source: | Medical oncology (Northwood, London, England) [Med Oncol] 2025 Aug 04; Vol. 42 (9), pp. 405. Date of Electronic Publication: 2025 Aug 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9435512 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-131X (Electronic) Linking ISSN: 13570560 NLM ISO Abbreviation: Med Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
